Expanded Access to NanoPac
NCT03756311 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2026-01-23
Summary
NanOlogy may consider offering expanded access to NanoPac for patients who do not meet the enrollment criteria of clinical trials in progress.
Conditions
- Locally Advanced Pancreatic Carcinoma
- Prostate Cancer
- Lung Cancer
Interventions
- DRUG
-
NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
Sponsors & Collaborators
-
NanOlogy, LLC
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
NCT00553462 ·Status: COMPLETED ·Phase: PHASE2
-
Single Arm on the Tolerability of Weekly Nab-paclitaxel
NCT01702844 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC
NCT03219762 ·Status: UNKNOWN ·Phase: PHASE2
-
Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00005646 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.
NCT00386555 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer
NCT03520686 ·Status: TERMINATED ·Phase: PHASE3
-
Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma
NCT03361319 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy
NCT04151563 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
NCT03087708 ·Status: TERMINATED ·Phase: PHASE2
-
Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC
NCT03689855 ·Status: COMPLETED ·Phase: PHASE2
-
Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost
NCT06627738 ·Status: RECRUITING ·Phase: PHASE2
-
Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer
NCT01969955 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer
NCT00735696 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
NCT04234113 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer
NCT02831491 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung
NCT01236716 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer
NCT00977561 ·Status: TERMINATED ·Phase: PHASE2
-
Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery
NCT00217607 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer
NCT02250326 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
NCT01222572 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer
NCT00603538 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC
NCT02392507 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer
NCT01620190 ·Status: COMPLETED ·Phase: PHASE2
-
Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
NCT03997448 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
NCT02941601 ·Status: WITHDRAWN ·Phase: PHASE2